Covid-19 vaccine: Serum India ties up with Novavax for exclusive rights to its vaccine in India




According to a report by news agency Reuters, apart from the exclusive production and development license of the vaccine in India, Serum institute has also struck a deal to get non-exclusive rights to produce the drug in other developing nations as well.



Source link

Leave a Comment

Your email address will not be published.